These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7596034)

  • 1. Combined effects of pravastatin and probucol on high-density lipoprotein apolipoprotein A-I kinetics in cholesterol-fed rabbits.
    Saku K; Liu R; Jimi S; Matsuo K; Yamamoto K; Yanagita T; Arakawa K
    Jpn Circ J; 1995 May; 59(5):292-8. PubMed ID: 7596034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits.
    Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K
    Biochim Biophys Acta; 1990 Dec; 1047(3):247-54. PubMed ID: 2123720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.
    Ou J; Saku K; Jimi S; Liao YL; Ohta T; Zhang B; Arakawa K
    Jpn Circ J; 1999 Jun; 63(6):471-7. PubMed ID: 10406588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
    Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
    Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice.
    Hayek T; Chajek-Shaul T; Walsh A; Azrolan N; Breslow JL
    Arterioscler Thromb; 1991; 11(5):1295-302. PubMed ID: 1911715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
    Kagami A; Ishikawa T; Tada N; Sakamoto T; Mochizuki K; Nagano M; Moriguchi EH; Manabe M
    Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of HDL cholesterol esters to the liver is not diminished by probucol treatment in rats.
    Richard BM; Pfeuffer MA; Pittman RC
    Arterioscler Thromb; 1992 Jul; 12(7):862-9. PubMed ID: 1616911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit.
    Tawara K; Ishihara M; Ogawa H; Tomikawa M
    Jpn J Pharmacol; 1986 Jun; 41(2):211-22. PubMed ID: 3747267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits.
    Hong SC; Zhao SP; Wu ZH
    Int J Cardiol; 2007 Jan; 115(1):29-35. PubMed ID: 16766063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation of high density lipoprotein (HDL) using anti-apo A-I, apo A-II immuno-affinity chromatography to evaluate the effects of probucol].
    Kagami A; Hino K; Mochizuki K; Sakamoto T; Tada N; Ishikawa T; Manabe M; Satoh N
    Nihon Ronen Igakkai Zasshi; 1991 Nov; 28(6):748-54. PubMed ID: 1795436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice.
    Tsujita M; Tomimoto S; Okumura-Noji K; Okazaki M; Yokoyama S
    Biochim Biophys Acta; 2000 May; 1485(2-3):199-213. PubMed ID: 10832100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet.
    Bräsen JH; Harsch M; Niendorf A
    Virchows Arch; 1998 Jun; 432(6):557-62. PubMed ID: 9672198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of pravastatin on serum lipids, apoproteins, and lipoprotein (a) in primary hypercholesterolemia].
    Galetta F; Sampietro T; Basta G; Bionda A
    Minerva Med; 1994 Jun; 85(6):321-6. PubMed ID: 8084435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia.
    Fellin R; Gasparotto A; Valerio G; Baiocchi MR; Padrini R; Lamon S; Vitale E; Baggio G; Crepaldi G
    Atherosclerosis; 1986 Jan; 59(1):47-56. PubMed ID: 3081013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin sodium, an inhibitor of HMG-CoA reductase, decreases HDL cholesterol by transfer of cholesteryl ester from HDL to VLDL in Japanese white rabbits.
    Miyazaki A; Koieyama T; Shimada Y; Kikuchi T; Ito K; Kasanuki N; Koga T
    J Atheroscler Thromb; 2004; 11(1):22-8. PubMed ID: 15067195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
    Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
    Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro.
    Trezzi E; Roma P; Bernini F; Fumagalli R; Catapano AL
    Atherosclerosis; 1984 Sep; 52(3):309-16. PubMed ID: 6093829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome.
    Kobayashi J; Murano S; Yokote K; Mori S; Matsunaga A; Sasaki J; Takahashi K; Bujo H; Saito Y
    Clin Chim Acta; 2000 Mar; 293(1-2):63-73. PubMed ID: 10699423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.